Willow Biosciences Partners with Global Manufacturer to Launch Sustainable Ingredient
Slice of Manufacturing Team
Nov 11, 2024
Key Highlights:
- Willow Biosciences partners with global ingredient manufacturer for commercialization.
- R&D payments of up to $1.3M anticipated for Willow in the next 12 months.
- 15-year tiered profit-sharing agreement following successful launch.
- Partnership aims to replace chemically synthesized products with bioidentical, sustainable alternatives.
- Willow’s FutureGrown™ and BioOxi™ platforms support scalable, eco-friendly production.
Source: PR Newswire
Quotes
“ “We are pleased to partner this ingredient that started as an internal program, with a global partner with commercial-scale manufacturing expertise and market access.” ”
Dr. Chris Savile, President and CEO at Willow
Our Take:
This partnership underscores Willow Biosciences' commitment to transforming ingredient manufacturing through biotechnology. With its fully integrated tech platform, Willow is positioned to penetrate a billion-dollar market with a sustainable, high-purity alternative to existing synthetic products. This collaboration is a strong validation of Willow’s biomanufacturing capability and its potential to disrupt large markets dominated by conventional chemistry-based manufacturing. The success of this venture could set a new standard in functional ingredient production, aligning with broader sustainability goals in the health, wellness, and personal care industries.
